Literature DB >> 19802712

Leptin therapy in lipodystrophy.

D B Savage1, S O'Rahilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19802712     DOI： 10.1007/s00125-009-1545-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  21 in total

1.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

Review 3.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

4.  Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy.

Authors:  Kristina M Utzschneider; Dace L Trence
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

5.  The effect of diet on thermogenesis in acquired lipodystrophy.

Authors:  D C Robbins; E Danforth; E S Horton; R L Burse; R F Goldman; E A Sims
Journal:  Metabolism       Date:  1979-09       Impact factor: 8.694

6.  Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety).

Authors:  A Garg
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

Authors:  I Shimomura; R E Hammer; S Ikemoto; M S Brown; J L Goldstein
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

8.  Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.

Authors:  Edward D Javor; Stephanie Ann Moran; Janice Ryan Young; Elaine K Cochran; Alex M DePaoli; Elif Arioglu Oral; Martin A Turman; Piers R Blackett; David B Savage; Stephen O'Rahilly; James E Balow; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

Review 9.  Disordered lipid metabolism and the pathogenesis of insulin resistance.

Authors:  David B Savage; Kitt Falk Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

10.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

Authors:  I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808
View more
  3 in total

Review 1.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

2.  Leptin in relation to the lipodystrophy-associated metabolic syndrome.

Authors:  Christos S Mantzoros
Journal:  Diabetes Metab J       Date:  2012-06-14       Impact factor: 5.376

3.  Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions.

Authors:  Mojdeh Dormishian; Gulen Turkeri; Kyoji Urayama; Thu Lan Nguyen; Mounia Boulberdaa; Nadia Messaddeq; Gilles Renault; Daniel Henrion; Canan G Nebigil
Journal:  J Am Heart Assoc       Date:  2013-10-23       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.